AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 102 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,000 | -20.0% | 11,352 | -2.6% | 0.00% | – |
| Q1 2019 | $10,000 | -44.4% | 11,651 | +2.9% | 0.00% | – |
| Q4 2018 | $18,000 | -57.1% | 11,328 | -10.9% | 0.00% | – |
| Q3 2018 | $42,000 | +40.0% | 12,709 | -5.1% | 0.00% | – |
| Q2 2018 | $30,000 | -61.5% | 13,387 | -74.5% | 0.00% | -100.0% |
| Q1 2014 | $78,000 | -26.4% | 52,495 | +2.4% | 0.00% | -66.7% |
| Q3 2013 | $106,000 | +7.1% | 51,277 | +29.0% | 0.00% | +50.0% |
| Q2 2013 | $99,000 | – | 39,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $1,884,000 | 100.00% |
| Prosight Management, LP | 1,057,690 | $2,951,000 | 2.17% |
| NEA Management Company, LLC | 16,362,694 | $45,652,000 | 1.89% |
| EMORY UNIVERSITY | 602,883 | $1,682,000 | 1.44% |
| New Leaf Venture Partners, L.L.C. | 964,520 | $2,691,000 | 1.26% |
| RA Capital Management | 5,062,759 | $14,125,000 | 1.18% |
| Avoro Capital Advisors LLC | 4,006,893 | $11,179,000 | 0.72% |
| 683 Capital Management, LLC | 2,500,000 | $6,975,000 | 0.59% |
| X-Square Capital, LLC | 199,345 | $557,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,627,000 | 0.43% |